EAM
GILD icon

Exane Asset Management’s Gilead Sciences GILD Stock Holding History

Exane Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,013
Closed -$3.38M – 37
2019
Q2 		$3.38M Buy
50,013
+2,013
+4% +$132K 1.5% 23
2019
Q1 		$3.12M Buy
48,000
+26,169
+120% +$1.74M 1.52% 23
2018
Q4 		$1.37M Sell
21,831
-162,624
-88% -$11.4M 0.8% 24
2018
Q3 		$14.2M Buy
184,455
+166,055
+902% +$12.5M 4.46% 6
2018
Q2 		$1.3M Sell
18,400
-14,654
-44% -$1.03M 0.56% 32
2018
Q1 		$2.49M Sell
33,054
-249,492
-88% -$19.8M 0.75% 27
2017
Q4 		$20.2M Sell
282,546
-277,041
-50% -$21M 6.29% 7
2017
Q3 		$45.3M Buy
559,587
+225,985
+68% +$17.3M 8.86% 1
2017
Q2 		$23.6M Buy
333,602
+74,982
+29% +$4.99M 7.36% 3
2017
Q1 		$17.6M Buy
258,620
+8,331
+3% +$586K 5.45% 7
2016
Q4 		$17.9M Sell
250,289
-7,470
-3% -$555K 5.9% 6
2016
Q3 		$20.4M Buy
257,759
+66,804
+35% +$5.43M 6.39% 2
2016
Q2 		$15.9M Buy
190,955
+190,782
+110,279% +$16.9M 6.18% 5
2016
Q1 		$15.9K Sell
173
-80,623
-100% -$7.27M 0.01% 24
2015
Q4 		$8.18M Buy
+80,796
New +$8.41M 4.96% 7

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exane Asset Management's GILD Position: Q3 2019 in Review

Exane Asset Management sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 50,013 shares — an estimated $3.38M sold.

Exane Asset Management first reported a position in GILD in Q4 2015 and held it in 15 quarters. The position peaked at $45.3M in Q3 2017. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Exane Asset Management reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • Exane Asset Management sold 50,013 Gilead Sciences shares in Q3 2019, an estimated $3.38M.
  • Exane Asset Management first reported a position in Gilead Sciences in Q4 2015 and held it in 15 quarters.
  • Exane Asset Management's Gilead Sciences position peaked at $45.3M in Q3 2017.
  • 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Exane Asset Management's 13F filing for Q3 2019, filed 24 Oct 2019.